These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1105875)
1. Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in man. Collen D; Verstraete M Thromb Diath Haemorrh; 1975 Nov; 34(2):403-8. PubMed ID: 1105875 [No Abstract] [Full Text] [Related]
2. Molecular biology of human plasminogen. I. Physiochemical properties and microheterogeneity. Collen D; de Maeyer L Thromb Diath Haemorrh; 1975 Nov; 34(2):396-402. PubMed ID: 806 [No Abstract] [Full Text] [Related]
3. The activation mechanism of human plasminogen. Rickli EE Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150 [No Abstract] [Full Text] [Related]
4. Sialic acid content of plasminogen 2 glycoforms as a regulator of fibrinolytic activity. Isolation, carbohydrate analysis, and kinetic characterization of six glycoforms of plasminogen. Pirie-Shepherd SR; Jett EA; Andon NL; Pizzo SV J Biol Chem; 1995 Mar; 270(11):5877-81. PubMed ID: 7890718 [TBL] [Abstract][Full Text] [Related]
5. The activation and inhibition of fibrinolysis. Castellino FJ; Schick LA; Brockway WJ; Sodetz JM Adv Exp Med Biol; 1975; 63():233-43. PubMed ID: 128278 [No Abstract] [Full Text] [Related]
6. [Endogenous and exogenous fibrinolysis]. Perlick E; Wilfert K Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):28-32. PubMed ID: 4189368 [No Abstract] [Full Text] [Related]
8. [Animal experimental studies on fibrinolysis with streptokinase]. Hauptmann J; Klöcking HP Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):915-22. PubMed ID: 94886 [TBL] [Abstract][Full Text] [Related]
9. Interaction of human plasminogen with deoxyribonucleic acids. II. Protection of human plasminogen against catalytic activation with deoxyribonucleic acids. Hakim AA Enzymologia; 1970 Jan; 38(1):57-81. PubMed ID: 4244649 [No Abstract] [Full Text] [Related]
10. Composition and susceptibility to thrombolysis of pathological human arterial thrombi. Brommer EJ; Potter van Loon BJ; Rijken DC; van Bockel JH Ann N Y Acad Sci; 1992 Dec; 667():283-5. PubMed ID: 1309047 [No Abstract] [Full Text] [Related]
11. [The behavior of coagulation and fibrinolysis factors with different streptokinase doses]. Poliwoda H; Krohn HP; Steuber H Med Lab (Stuttg); 1968 Nov; 21(11):252-61. PubMed ID: 5714595 [No Abstract] [Full Text] [Related]
12. [A method for determining plasmin by the rate of fibrin gel lysis]. Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408 [TBL] [Abstract][Full Text] [Related]
16. Studies on activator formation in human plasma with streptokinase. II. Quantitative activator and plasminogen measurements during continuous and intermittent streptokinase infusion. Martin M Thromb Diath Haemorrh; 1973 Nov; 30(2):393-402. PubMed ID: 4773378 [No Abstract] [Full Text] [Related]
17. The mechanism of activation of human plasminogen by streptokinase. McClintock DK; Bell PH Biochem Biophys Res Commun; 1971 May; 43(3):694-702. PubMed ID: 4254608 [No Abstract] [Full Text] [Related]
18. Studies on fluidity of blood on the basis of fibrinolysis. 8. Analysis of fibrinolytic activity of the human blood activated with streptokinase and urokinase in vitro--with special reference to its similarity to fibrinolytic activity of fluid corpse blood. Ishizu H; Nobuhara M; Takata H Nihon Hoigaku Zasshi; 1971 Sep; 25(3):366-72. PubMed ID: 5167453 [No Abstract] [Full Text] [Related]